No Data
No Data
Express News | Quoin Pharmaceuticals Expands Netherton Syndrome Clinical Studies Internationally; First Site to Open in Saudi Arabia; Engages Experienced Local Clinical Research Organization; Plans for Additional Sites at Advanced Stage
Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference
Maxim Group Maintains Quoin Pharmaceuticals(QNRX.US) With Buy Rating, Maintains Target Price $4
Express News | Quoin Pharmaceuticals Signs Research Agreement With University College Cork Encompassing The Development Of Topical Formulations Of Rapamycin
Quoin Pharmaceuticals Announces Signing of Research Agreement With University College Cork (UCC), Ireland
No Data